BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors

Haanen, John B. A. G. and Mackensen, Andreas and Koenecke, Christian and Alsdorf, Winfried and Wagner-Drouet, Eva and Heudobler, Daniel and Borchmann, Peter and Bokemeyer, Carsten and Klobuch, Sebastian and Desuki, Alexander and Lueke, Florian and Wiegert, Erol and Schulz, Catrine and Rengstl, Benjamin and Preussner, Liane and Tuereci, Oezlem and Sahin, Ugur (2022) BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors. CANCER RESEARCH, 82 (12supp): CT002. ISSN 0008-5472, 1538-7445

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 27 Feb 2025 11:06
Last Modified: 27 Feb 2025 11:06
URI: https://pred.uni-regensburg.de/id/eprint/57913

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.